Clinical Trials Directory

Trials / Completed

CompletedNCT04376411

Role of Regulatory B Cells in Behçet's Disease

Possible Role of Regulatory B Cells in Behçet's Disease: Special Interest in Cardiovascular System

Status
Completed
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

There are limited data about the role of regulatory B cells in Behcet Disease. In this study we aimed to identify the proportions of total B lymphocytes and their regulatory subset in different Behcet Disease phenotype and therapies concentrating on the cardiovascular system attempting to unravel their function in Behcet Disease.

Detailed description

Behçet's disease is a chronic multi-organ vasculitis characterized by recurrent oral and genital aphthae, skin lesions, widespread thrombosis and aneurysmal formation, and serious involvement of the eyes and central nervous system. The innate and adaptive immune cells integrate in the pathogenesis of Behçet's disease. Interestingly, the gene expression analysis of Behçet's disease patients and healthy controls revealed the modulation of a range of genes involved in biological processes in Behçet's disease such as inflammation, apoptosis, angiogenesis, blood coagulation, vascular damage, signalling pathways, and immune responses, particularly, in innate immune cells, Th17 cells and B cells. Yet, the regulatory role of B cells in Behçet's disease has not been thoroughly investigated. Therefore, the aim of the current study is to identify the proportions of total B lymphocytes and their regulatory subset in different Behçet's disease phenotypes and therapies attempting to unravel their function in Behcet Disease. The role of B cells and regulatory B cells in the cardiovascular system affection in Behcet Disease was studied in more details.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFlow-cytometric assay100 µl of blood sample was incubated for 20 minutes at 4 C in the dark. Following incubation, red blood cells lysis, washing and analysis a specific software.Forward and side scatter histogram was used to define the lymphocytes population.
DIAGNOSTIC_TEST2D Echocardiographic analysisTrans thoracic echocardiographic examination was performed through (PHILIPS -33) echocardiography device with broadband S5-1 transducer
DIAGNOSTIC_TESTTwo-Dimensional speckle tracking echocardiographyTwo-Dimensional speckle tracking echocardiography was performed on grey scale images of the left ventricle. For offline analysis digital storage software (Qlab 10.4) was used. The frame rate was adjusted to be 60-90 frame/second.

Timeline

Start date
2018-12-15
Primary completion
2019-03-30
Completion
2019-12-15
First posted
2020-05-06
Last updated
2020-05-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04376411. Inclusion in this directory is not an endorsement.